Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

2.120 +0.040 (+1.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,301,933
Open 2.050
Bid (Size) 2.140 (1)
Ask (Size) 2.150 (30)
Prev. Close 2.080
Today's Range 1.960 - 2.269
52wk Range 0.7720 - 2.220
Shares Outstanding 15,873,941
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INDP),(NYSE:CATX),(NASDAQ:SLS),(NASDAQ:AUTL EQNX::TICKER_END 
Via FinancialNewsMedia
Thursday's after hours session: top gainers and losers
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill

Performance

YTD
+98.1%
+98.1%
1 Month
+34.2%
+34.2%
3 Month
+94.5%
+94.5%
6 Month
+103.8%
+103.8%
1 Year
+79.7%
+79.7%

More News

Read More
Top movers in Tuesday's after hours session
Via Chartmill
Why Sellas Life Sciences Shares Are Nosediving
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
What's going on in today's after hours session
Via Chartmill
These stocks are moving in today's session
Via Chartmill
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
SLS Stock Earnings: SELLAS Life Sciences Gr Beats EPS for Q2 2024
Via InvestorPlace
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
Via FinancialNewsMedia
SLS Stock Earnings: SELLAS Life Sciences Gr Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
From FN Media Group LLC
Via GlobeNewswire
SLS Stock Earnings: SELLAS Life Sciences Gr Misses EPS for Q4 2023
Via InvestorPlace
Dow Falls Over 200 Points; Adobe Shares Plunge
Via Benzinga
Topics Stocks
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Edges Lower; US Consumer Sentiment Falls In March
Via Benzinga
Topics Stocks
Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Zijin Mining Invests $97M In Solaris Resources, Deal To Bolster Copper Project In Ecuador
Via Benzinga
Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is SELLAS Life Sciences Group, Inc. - Common Stock publicly traded?
Yes, SELLAS Life Sciences Group, Inc. - Common Stock is publicly traded.
What exchange does SELLAS Life Sciences Group, Inc. - Common Stock trade on?
SELLAS Life Sciences Group, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock?
The ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock is SLS on the Nasdaq Stock Market
What is the current price of SELLAS Life Sciences Group, Inc. - Common Stock?
The current price of SELLAS Life Sciences Group, Inc. - Common Stock is 2.120
When was SELLAS Life Sciences Group, Inc. - Common Stock last traded?
The last trade of SELLAS Life Sciences Group, Inc. - Common Stock was at 07/02/25 04:00 PM ET
What is the market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock?
The market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock is 33.65M
How many shares of SELLAS Life Sciences Group, Inc. - Common Stock are outstanding?
SELLAS Life Sciences Group, Inc. - Common Stock has 34M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.